The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan by Fust, Kelly, Joshi, Keya, Beck, Ekkehard, Maschio, Michael, Kohli, Michele, Lee, Amy, Hagiwara, Yuriko, Van de Velde, Nicolas, Igarashi, Ataru

Get full text

Clinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2023 vaccines in Germany by Joshi, Keya, Scholz, Stefan, Maschio, Michael, Kohli, Michele, Lee, Amy, Fust, Kelly, Ultsch, Bernhard, Van de Velde, Nicolas, Beck, Ekkehard

Get full text

The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA fall 2023 vaccines in the United States by Kohli, Michele A, Maschio, Michael, Joshi, Keya, Lee, Amy, Fust, Kelly, Beck, Ekkehard, Van de Velde, Nicolas, Weinstein, Milton C

Get full text

The potential clinical impact of implementing different COVID-19 boosters in fall 2022 in the United States by Kohli, Michele A., Maschio, Michael, Lee, Amy, Fust, Kelly, Van de Velde, Nicolas, Buck, Philip O., Weinstein, Milton C.

Get full text

Cost Differences of Same-Day Vs Next-Day Use of Pegfilgrastim by Li, Xiaoyan, Zhang, Xinke, Lin, Junji, Fust, Kelly, Garcia, Jacob

Get full text

A Budget Impact Model of the Addition of Telotristat Ethyl Treatment to the Standard of Care in Patients with Uncontrolled Carcinoid Syndrome by Fust, Kelly, Maschio, Michael, Kohli, Michele, Singh, Simron, Pritchard, D. Mark, Marteau, Florence, Myrenfors, Peter, Feuilly, Marion

Get full text

116. Potential Clinical Impact of Respiratory Syncytial Virus (RSV) Vaccination in Older Adults in the United States by Fust, Kelly, Kohli, Michele, Panozzo, Catherine A, Weinstein, Milton C, Buck, Philip, Ghaswalla, Parinaz

Get full text

Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma by Fust, Kelly, Li, Xiaoyan, Maschio, Michael, Villa, Guillermo, Parthan, Anju, Barron, Richard, Weinstein, Milton C., Somers, Luc, Hoefkens, Caroline, Lyman, Gary H.

Get full text

Cost per Treatment Success of Thrombopoietin Receptor Agonists Vs "Watch and Rescue" Strategy for Treating Adult Non-Splenectomized Patients with Chronic Immune Thrombocytopenia: A... by Li, Xiaoyan, Sharma, Anjali, Zhang, Xinke, Campioni, Marco, Fust, Kelly, Lin, Junji, Parthan, Anju, Wang, Xuena, Zur, Richard, Cetin, Karynsa, Eisen, Melissa

Get full text

Cost-effectiveness of prophylaxis treatment strategies for febrile neutropenia in patients with recurrent ovarian cancer by Fust, Kelly, Li, Xiaoyan, Maschio, Michael, Barron, Richard, Weinstein, Milton C, Parthan, Anju, Walli-Attaei, Marjan, Chandler, David B, Lyman, Gary H

Get full text